...
首页> 外文期刊>Eurosurveillance >Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021
【24h】

Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021

机译:针对严重急性呼吸道感染的疫苗有效性(Sari)Covid-19住院住院,估计来自现实世界监测数据,斯洛文尼亚,10月2021年

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We estimated vaccine effectiveness (VE) against severe COVID-19 during October 2021, using Slovenian surveillance data. For people fully vaccinated with any vaccine in age groups 18–49, 50–64,?≥?65 years, VE was 86% (95% CI: 79–90), 89% (85–91), and 77% (74–81). Among?≥?65 year-olds fully vaccinated with mRNA vaccines, VE decreased from 93% (95% CI: 88–96) in those vaccinated?≤?3 months ago to 43% (95% CI: 30–54) in those vaccinated?≥?6 months ago, suggesting the need for early boosters.
机译:我们使用斯洛文尼亚监控数据估计了2021年10月20日的严重Covid-19疫苗效率(VE)。 对于与年龄组的任何疫苗完全接种疫苗,50-64,50-64,?≥65岁,ve为86%(95%CI:79-90),89%(85-91)和77%( 74-81)。 在疫苗中完全接种疫苗的?≥?65岁的疫苗中,在接种疫苗的93%(95%CI:88-96)下降(95%CI:88-96),≤?3个月前至43%(95%CI:30-54) 那些疫苗的疫苗?≥?6个月前,建议需要提前助推器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号